Omar Ishrak — slated to step down as CEO of Medtronic (NYSE:MDT) in April — is now the independent chair of the board at tech giant Intel (NSDQ:INTC).

Ishrak replaces Andy Bryant, who plans to retire from Intel’s board in May.

“I have full confidence in Omar leading the board, which is fortunate to have his expertise at leading an innovative, global company,” Bryant said in a news release out yesterday.

Ishrak is also staying on at Medtronic in a newly created executive chairman role, with longtime lieutenant Geoff Martha taking over the corner office at the medical device giant. Industry watchers have credited Ishrak for using a series of M&A moves and focus on global markets and value-based care to transform Medtronic into the world’s largest medical device business in less than a decade.